| Ms Preeti Lalitha Mokka, OD | |
|
300 Longwood Ave, Boston, MA 02115-5724 | |
| (617) 355-6000 | |
| Not Available |
| Full Name | Ms Preeti Lalitha Mokka |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 300 Longwood Ave, Boston, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124412465 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 5055 (Massachusetts) | Primary |
| Provider Name | Childrens Hospital Ophthalmology Foundation Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1770679045 PECOS PAC ID: 8729049150 Enrollment ID: O20041020000189 |
News Archive
Fewer than three doses of the human papillomavirus (HPV) vaccine Cervarix may be just as effective as the standard three-dose regimen when it comes to preventive measures against cervical cancer, according to a new study published September 9 in the Journal of the National Cancer Institute.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of clinical studies using Uroplasty's Urgent PC Neuromodulation System and Macroplastique urethral bulking agent products are scheduled to be presented at three upcoming professional meetings.
Anesiva, Inc. today announced that on November 5, 2009, it received a letter from The NASDAQ Stock Market LLC stating that the Nasdaq Hearing Panel has granted Anesiva's request for continued listing on The NASDAQ Global Market subject to the condition that Anesiva shall have completed on or before December 31, 2009, the proposed merger (the "Merger") contemplated by the Agreement and Plan of Merger, dated August 4, 2009, among Anesiva, Arca Acquisition Corporation ("Arca"), a wholly-owned subsidiary of Anesiva, Arcion Therapeutics, Inc. ("Arcion") and, with respect to Articles V and IX only of the agreement, each of the Arcion stockholders listed on Schedule I thereto.
Preventable medical errors of various kinds kill at least 200,000 Americans each year, making this the third leading cause of death in the United States, six times as many deaths as from auto accidents. One way to reduce such errors is for consumers to choose the best surgeons. For the first time ever, consumers across the U.S. today have access to ratings of individual surgeons based on outcomes—how often their patients die in hospital or within 90 days of hospital discharge, have serious complications in hospital, or need to be readmitted to a hospital within 90 days of discharge.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Preeti Lalitha Mokka, OD 300 Longwood Ave, Boston, MA 02115-5724 Ph: () - | Ms Preeti Lalitha Mokka, OD 300 Longwood Ave, Boston, MA 02115-5724 Ph: (617) 355-6000 |
News Archive
Fewer than three doses of the human papillomavirus (HPV) vaccine Cervarix may be just as effective as the standard three-dose regimen when it comes to preventive measures against cervical cancer, according to a new study published September 9 in the Journal of the National Cancer Institute.
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced that the results of clinical studies using Uroplasty's Urgent PC Neuromodulation System and Macroplastique urethral bulking agent products are scheduled to be presented at three upcoming professional meetings.
Anesiva, Inc. today announced that on November 5, 2009, it received a letter from The NASDAQ Stock Market LLC stating that the Nasdaq Hearing Panel has granted Anesiva's request for continued listing on The NASDAQ Global Market subject to the condition that Anesiva shall have completed on or before December 31, 2009, the proposed merger (the "Merger") contemplated by the Agreement and Plan of Merger, dated August 4, 2009, among Anesiva, Arca Acquisition Corporation ("Arca"), a wholly-owned subsidiary of Anesiva, Arcion Therapeutics, Inc. ("Arcion") and, with respect to Articles V and IX only of the agreement, each of the Arcion stockholders listed on Schedule I thereto.
Preventable medical errors of various kinds kill at least 200,000 Americans each year, making this the third leading cause of death in the United States, six times as many deaths as from auto accidents. One way to reduce such errors is for consumers to choose the best surgeons. For the first time ever, consumers across the U.S. today have access to ratings of individual surgeons based on outcomes—how often their patients die in hospital or within 90 days of hospital discharge, have serious complications in hospital, or need to be readmitted to a hospital within 90 days of discharge.
› Verified 7 days ago
Dr. Ying Zhou, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1341 Boylston St, Target Optical, Boston, MA 02215 Phone: 857-654-5912 | |
Justine Pidgeon, OD Optometrist Medicare: Medicare Enrolled Practice Location: 400 Commonwealth Ave Ste 2, Boston, MA 02215 Phone: 617-426-0370 | |
Dr. Brittney Jaye Mazza, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 930 Commonwealth Ave, Suite 2a, Boston, MA 02215 Phone: 617-262-2020 | |
Boston Telehealth Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 424 Beacon St, Boston, MA 02115 Phone: 617-834-3245 | |
Ms. Ceida P Chan, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 780 Albany St, Boston, MA 02118 Phone: 857-654-1000 Fax: 857-654-1100 | |
Dr. Howard S Harrison, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 33 Broad St, Lobby, Boston, MA 02109 Phone: 617-742-7200 Fax: 617-742-7272 | |
Dr. Doug Rett, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 150 S Huntington Ave, Optometry 8th Floor, Boston, MA 02130 Phone: 617-548-9208 |